MAPT and tauopathy: Chalermpalanupap et al. utilized a selective neurotoxin, DSP-4, that targets noradrenergic cells of the LC, to investigate the effects of LC ablation longitudinally across three time points in a mouse-model of tauopathy (P301S tau) in comparison to wild-type and non-LC-ablated P301S mice.